Kerafast Acquired by LSBio We are excited to share that Kerafast and its sister company Absolute Antibody have been acquired by the reagent company LSBio. The acquisition will enable the continued growth of the Kerafast catalog, while further extending the global reach of the unique reagents made available via our program. It’s business as usual for our customers and partners, and your experience with Kerafast will remain the same. You can read more about the details here.
Kerafast Recognized for Support in Developing a COVID-19 Vaccine BioNTech recently published an announcement expressing gratitude to its employees and various partners who assisted in developing the successful BioNTech-Pfizer COVID-19 vaccine. Kerafast is very proud to be mentioned as one of the contributing companies, providing research reagents including a VSV-G antibody, plasmids from the Delta-G VSV pseudotyping system, and a dsRNA antibody from Absolute Antibody. Read more about our contributions and the vaccine here.
10 Reagents that Accelerated Research in 2020 Each year we enjoy looking back at how the reagents in our catalog helped contribute to scientific progress over the past year. Read our new blog post to learn about 10 unique reagents that were used in peer-reviewed research in 2020 to further our understanding of science and disease, especially during the coronavirus pandemic. Highlighted reagents include the Delta-G-VSV System, Recombinant Coronavirus Antibodies, Yeast-Display Nanobody Library and more.
Kerafast Lab Manager Contest This past holiday season we ran a lab manager contest to highlight the amazing lab managers across the world who work so hard to support their teams. Winners were randomly selected, and we’re happy to announce that Amandine Blanco from the University of Lyon (pictured with her lab) and Mike Schmidtke from Wayne State University both won a $1,000 gift card plus $250 for their lab! We interviewed both Amandine and Mike about their research careers and personal interests, both of which you can read on our blog. We love running these contests, so stayed tuned for more in the future.
Featured Lab
Goutham Narla, MD, PhD, Icahn School of Medicine at Mouse Sinai We are excited to feature the Narla Lab on our homepage this quarter! The Narla laboratory focuses on the identification and characterization of the genes and pathways involved in cancer metastasis. Dr. Narla was the first to identify that KLF6 was a tumor suppressor gene in cancer with his mentor. He now offers a KLF6 [2A2] Antibody and the KLF6, Splice Variant 1 [9A2] Antibody in our reagent catalog.
We are excited to share that Kerafast and its sister company Absolute Antibody have been acquired by the reagent company LSBio. The acquisition will enable the continued growth of the Kerafast catalog, while further extending the global reach of the unique reagents made available via our program. It’s business as usual for our customers and partners, and your experience with Kerafast will remain the same. You can read more about the details 
BioNTech recently published an announcement expressing gratitude to its employees and various partners who assisted in developing the successful BioNTech-Pfizer COVID-19 vaccine. Kerafast is very proud to be mentioned as one of the contributing companies, providing research reagents including a 
Each year we enjoy looking back at how the reagents in our catalog helped contribute to scientific progress over the past year. 
This past holiday season we ran a lab manager contest to highlight the amazing lab managers across the world who work so hard to support their teams. Winners were randomly selected, and we’re happy to announce that Amandine Blanco from the University of Lyon (pictured with her lab) and Mike Schmidtke from Wayne State University both won a $1,000 gift card plus $250 for their lab! We interviewed both Amandine and Mike about their research careers and personal interests, both of which you can read 
